Who Owns Adcock Ingram?
Adcock Ingram is the flagship brand of Adcock Ingram Holdings Limited, the South African pharmaceutical group controlled by The Bidvest Group with NATCO Pharma holding 35.75%. With roots to an 1891 Krugersdorp pharmacy, its medicine-cabinet brands include Panado, Myprodol, Epi-Max and Citro-Soda. The company delisted from the JSE in November 2025.
Parent Company
Founded
1891
Status
Private
Headquarters
Who Owns Adcock Ingram?
- Parent Company: Adcock Ingram Holdings Limited
- Ownership Type: Brand division
- Company Type: Privately Held
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Adcock Ingram | Adcock Ingram Holdings Limited | Brand division |
Where to Buy
Disclosure: We may earn commission from purchases
Adcock Ingram on AmazonAdvertisement
History of Adcock Ingram
- Founded: 1891
- Founders: E. J. Adcock
The brand's lineage reaches to 1891, when E.J. Adcock opened a pharmacy in Krugersdorp in the South African Republic, making it one of the country's oldest pharmaceutical names. The Adcock and Ingram pharmaceutical houses merged over the twentieth century into the modern entity.
Through the mid-twentieth century the company built its consumer franchise on analgesics: Panado became South Africa's leading paracetamol and Myprodol a household name, joined later by Epi-Max skincare and Citro-Soda. Tiger Brands owned it as a healthcare arm from the 1970s before unbundling it into a separate JSE listing in 2008.
The Bidvest Group built control through the 2010s, and the company's Indian manufacturing interests expanded. In July 2025 NATCO Pharma announced its acquisition of all shares not held by Bidvest at R75 per share; shareholders approved in October and the company delisted on 11 November 2025, now operating privately.
Advertisement
About Adcock Ingram Holdings Limited
Who owns Adcock Ingram?
The Bidvest Group is the controlling shareholder, with India's NATCO Pharma holding 35.75% since November 2025. The company delisted from the JSE on 11 November 2025.
Is Adcock Ingram still listed on the JSE?
No. Adcock Ingram Holdings delisted on 11 November 2025 after NATCO Pharma acquired the minority shares at R75 per share in a transaction valued at about ZAR 4 billion.
When was Adcock Ingram founded?
The company's roots trace to E.J. Adcock's pharmacy in Krugersdorp in 1891, making it one of South Africa's oldest pharmaceutical businesses.
What brands does Adcock Ingram make?
Its best-known brands include Panado, Myprodol, Epi-Max, Citro-Soda, Allergex, Corenza C, Alcophyllex and Bioplus, plus extensive prescription and hospital product lines.
Advertisement
Where is Adcock Ingram headquartered?
The company is headquartered in Midrand, Gauteng, South Africa, with manufacturing facilities including its Wadeville plant and interests in India.
Why did NATCO Pharma invest in Adcock Ingram?
NATCO described the 35.75% acquisition as its entry into the South African market, gaining an established manufacturing base, distribution network and trusted local brands.
- Founded: 1891
- Headquarters: Midrand, Gauteng, South Africa
- Company Type: Privately Held
- Revenue: R9.76 billion (FY2025, ended 30 June 2025)
- Employees: Approximately 4,000
Where Is Adcock Ingram Made / Based?
- Headquarters: Midrand, Gauteng, South Africa
- Manufacturing / Operations: South Africa, India
Adcock Ingram Categories & Tags
Adcock Ingram Sustainability & Ethics
The company operates under pharmaceutical manufacturing standards including SAHPRA oversight and maintains B-BBEE level 1 status, the highest transformation rating in South Africa. Its consumer products are regulated medicines with manufacturer-level safety monitoring. It holds no consumer-facing certifications like Leaping Bunny, appropriate for a pharmaceutical manufacturer.
Adcock Ingram Recalls & Controversies
The brand's record includes industry-standard pharmaceutical recalls executed under SAHPRA oversight over the years, typical for a large medicine manufacturer. The November 2025 delisting itself drew scrutiny over minority exit pricing at R75 per share, though shareholders approved the scheme overwhelmingly. No major regulatory scandal defines its history.
Advertisement
Adcock Ingram Ownership: Pros & Cons
Advantages
- +Bidvest control provides capital and distribution synergies
- +NATCO partnership lowers manufacturing costs
- +Iconic consumer brands carry durable loyalty
- +Private ownership removes quarterly market pressure
Considerations
- -Concentrated two-block ownership limits minority input
- -Regulated drug pricing caps revenue growth
- -Manufacturing efficiency issues at Wadeville pressured margins
- -Integration with NATCO carries execution risk
Frequently Asked Questions About Adcock Ingram
Advertisement
Sources & Further Reading
Competitors to Adcock Ingram
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Amgen | USA | 1980 | Market leader | Global | All-ages | |
| Dis Chem Pharmacies | South Africa | 1978 | Mass market | Regional | All Genders | |
| Ge Healthcare | USA | 2023 | Mass market | Global | All Genders | |
| Amgen | USA (parent) | 2014 | Market leader | Global | All-ages | |
| Pacira Biosciences | USA | 2006 | Premium | United states | All Genders | |
| Amgen | USA (parent) | 2010 | Market leader | Global | All-ages |
Learn More About Competitors
Healthcare PharmaceuticalsAmgen
Owned by Amgen Inc.
Master biotechnology brand of Amgen Inc., the world's largest independent biotech, covering its full portfolio of biologic medicines.
biotechnologypharmaceuticalsbiologics
Healthcare PharmaceuticalsDis-Chem
Owned by Dis-Chem Pharmacies Limited
South Africa's leading discount pharmacy chain, founded 1978 by the Saltzmans and listed on the JSE since 2016.
pharmacyretailhealthcare
Healthcare PharmaceuticalsGE Diagnostics
Owned by GE HealthCare Technologies Inc.
Pharmaceutical Diagnostics business of GE HealthCare, producing contrast agents and molecular imaging tracers including Omnipaque, Clariscan, Vizamyl, and Flyrcado used in diagnostic scans worldwide.
pharmaceuticalscontrast-agentsdiagnostics
Healthcare PharmaceuticalsOtezla
Owned by Amgen Inc.
Oral medication for psoriasis and psoriatic arthritis owned by Amgen Inc., the leading non-injectable treatment in its class.
pharmaceuticalspsoriasispsoriatic-arthritis
Healthcare PharmaceuticalsPacira
Owned by Pacira BioSciences, Inc.
Pharmaceutical brand behind non-opioid pain therapies EXPAREL and ZILRETTA, owned by Pacira BioSciences and being acquired by Viatris for $1.65 billion.
pharmaceuticalspain-managementnon-opioid
Healthcare PharmaceuticalsProlia
Owned by Amgen Inc.
Biologic osteoporosis medication owned by Amgen Inc., the leading injectable treatment for bone density loss.
pharmaceuticalsbiologicsosteoporosis
Competitive Analysis
Market Positioning: Adcock Ingram competes with 6 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Advertisement
Independent Alternatives to Adcock Ingram
Looking for brands with different ownership structures? These similar brands are not owned by Adcock Ingram Holdings Limited, giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsCresco Labs
Owned by Cresco Labs Inc.
Chicago-based cannabis company operating Sunnyside dispensaries and leading wholesale brands like Cresco, High Supply, and FloraCal.
cannabisdispensarysunnyside
Publicly Traded
Cresco Labs operates independently without a large parent corporation.
Healthcare PharmaceuticalsDis-Chem
Owned by Dis-Chem Pharmacies Limited
South Africa's leading discount pharmacy chain, founded 1978 by the Saltzmans and listed on the JSE since 2016.
pharmacyretailhealthcare
Publicly Traded
Dis-Chem is owned by Dis-Chem Pharmacies Limited, a public company, a different structure than Adcock Ingram's parent.
Healthcare PharmaceuticalsNexon Pharma
Owned by Nexon Pharma Sp. z o.o.
Polish dietary supplement and medical device brand owned by Nexon Pharma Sp. z o.o. of Warsaw, sold through pharmacies.
supplementsmedical-devicespoland
Privately Owned
Nexon Pharma operates independently without a large parent corporation.
Healthcare PharmaceuticalsAmazon Pharmacy
Owned by Amazon.com Inc.
Amazon's online pharmacy service offering prescription medications and home delivery, operating as a division of Amazon.com Inc.
pharmacymedicationshealthcare
Publicly Traded
Amazon Pharmacy is owned by Amazon.com Inc., a public company, a different structure than Adcock Ingram's parent.
Healthcare PharmaceuticalsCVS Pharmacy
Owned by CVS Health Corporation
American pharmacy retail chain and one of the largest pharmacy networks in the United States, owned by CVS Health.
pharmacyretailhealthcare
Publicly Traded
CVS Pharmacy is owned by CVS Health Corporation, a public company, a different structure than Adcock Ingram's parent.
Healthcare PharmaceuticalsFiberCon
Owned by Prestige Consumer Healthcare Inc.
Calcium polycarbophil bulk-forming laxative brand marketed in caplet form, distributed by Medtech Products Inc., a Prestige Consumer Healthcare company, per 2026 FDA labeling.
fiber-supplementdigestive-healthcalcium-polycarbophil
Publicly Traded
FiberCon is owned by Prestige Consumer Healthcare Inc., a public company, a different structure than Adcock Ingram's parent.
Jobs at Adcock Ingram Holdings Limited
Advertisement
Latest News About Adcock Ingram
Related Articles About Adcock Ingram
View more articles
Health
The Pharmaceutical Giants Behind Common Medicines
Eli Lilly is now #1 pharma ($65.2B, Mounjaro + Zepbound). Novo Nordisk has 59.6% GLP-1 share. Merck's Keytruda is $31.7B. Pfizer faces a $20B patent cliff. Discover who makes your medicines. Explore our database.
Who Brands StaffNov 6, 2026
PharmaceuticalsEli LillyNovo Nordisk
Health
Who Makes Over the Counter Painkillers: Tylenol to Nurofen
Tylenol is Kenvue, days from becoming Kimberly-Clark in a ~$49B deal. Advil is Haleon (GSK spin-off). Aleve is Bayer. Nurofen is Reckitt. Discover who makes your painkillers.
Who Brands StaffNov 1, 2026
TylenolAdvilNurofen
Health
Generic vs Brand Name Drugs: Same Company or Different
Teva is the world's largest generic drugmaker (~6% US share). Sandoz was spun off Novartis in 2023. Viatris came from Mylan + Pfizer's Upjohn. Pfizer itself holds hundreds of ANDAs. Explore our database.
Who Brands StaffOct 30, 2026
Generic DrugsBrand NamePharmaceuticals
Advertisement
People Also Searched
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.
Brandgenetic-testing
23andMe
Consumer DNA testing brand now run as a nonprofit under TTAM Research Institute following the 2025 bankruptcy sale of 23andMe Holding Co.
Brand in Healthcare & Pharmaceuticals
dna-kitsconsumer-genomics
Brandpharmaceutical
Abbokinase
Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.
Brand in Healthcare & Pharmaceuticals
thrombolyticurokinase
Brandmedical-devices
Abbott Medical Devices
Abbott Laboratories' medical device business spanning cardiovascular, diabetes care (FreeStyle Libre), neuromodulation, and structural heart, generating roughly $20 billion annually.
Brand in Healthcare & Pharmaceuticals
cardiovasculardiabetes-care